Connective Capital Management LLC Invests $364,000 in Simulations Plus, Inc. (NASDAQ:SLP)

Connective Capital Management LLC purchased a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,835 shares of the technology company’s stock, valued at approximately $364,000. Simulations Plus makes up about 0.6% of Connective Capital Management LLC’s investment portfolio, making the stock its 18th biggest holding.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. EntryPoint Capital LLC bought a new stake in Simulations Plus in the 1st quarter valued at $57,000. Allspring Global Investments Holdings LLC bought a new stake in Simulations Plus in the 1st quarter valued at $70,000. Connecticut Wealth Management LLC bought a new stake in Simulations Plus in the 1st quarter valued at $204,000. Janney Montgomery Scott LLC bought a new stake in Simulations Plus in the 1st quarter valued at $208,000. Finally, Canton Hathaway LLC lifted its position in Simulations Plus by 25.0% in the 4th quarter. Canton Hathaway LLC now owns 5,000 shares of the technology company’s stock valued at $224,000 after acquiring an additional 1,000 shares in the last quarter. 78.08% of the stock is owned by institutional investors.

Simulations Plus Stock Performance

SLP traded down $0.09 on Tuesday, reaching $40.15. The company had a trading volume of 94,008 shares, compared to its average volume of 117,212. The stock has a market cap of $803.40 million, a P/E ratio of 83.65 and a beta of 0.72. Simulations Plus, Inc. has a fifty-two week low of $32.69 and a fifty-two week high of $52.69. The company’s fifty day moving average is $44.85 and its 200 day moving average is $43.88.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Tuesday, July 2nd. The technology company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. The firm had revenue of $18.54 million during the quarter, compared to the consensus estimate of $17.92 million. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.20 EPS. On average, sell-side analysts expect that Simulations Plus, Inc. will post 0.5 EPS for the current year.

Simulations Plus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, August 5th. Stockholders of record on Monday, July 29th will be issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date is Monday, July 29th. Simulations Plus’s dividend payout ratio (DPR) is presently 50.00%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on SLP shares. Craig Hallum reissued a “buy” rating and set a $56.00 price target on shares of Simulations Plus in a research report on Wednesday, July 3rd. JMP Securities started coverage on shares of Simulations Plus in a research report on Tuesday, July 16th. They set a “market perform” rating on the stock. William Blair started coverage on shares of Simulations Plus in a research report on Friday, June 28th. They set an “outperform” rating on the stock. Oppenheimer boosted their price target on shares of Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a research report on Thursday, June 13th. Finally, KeyCorp began coverage on shares of Simulations Plus in a research report on Monday. They set an “overweight” rating and a $47.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Insider Transactions at Simulations Plus

In other news, Director Daniel L. Weiner sold 3,250 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total transaction of $157,007.50. Following the completion of the sale, the director now owns 8,759 shares of the company’s stock, valued at approximately $423,147.29. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $45.95, for a total value of $919,000.00. Following the completion of the transaction, the director now directly owns 3,580,857 shares in the company, valued at approximately $164,540,379.15. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Daniel L. Weiner sold 3,250 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total transaction of $157,007.50. Following the completion of the transaction, the director now owns 8,759 shares of the company’s stock, valued at $423,147.29. The disclosure for this sale can be found here. In the last 90 days, insiders sold 44,500 shares of company stock valued at $2,072,198. Company insiders own 20.90% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.